We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Publication, Part of National Kidney Care Audit, Vascular Access
National Kidney Care Audit, Vascular Access - 2009
Audit- Publication Date:
- 27 May 2010
- Geographic Coverage:
- United Kingdom
- Geographical Granularity:
- Country, Hospital Trusts
- Date Range:
- 01 Jan 2009 to 31 Dec 2009
Summary
For a patient requiring long-term haemodialysis (HD) for established renal failure, vascular access is a crucial aspect of the therapy. Vascular access (VA) is required to remove and return blood to the patient, passing the blood through an artificial kidney or flter. Most patients have their treatment three times a week for four hours or more.
Highlights
Resources
Last edited: 7 February 2019 10:55 am